Skip to main content

Table 1 Characteristics of study sample

From: The impact of comorbidities on productivity loss in asthma patients

 

Study population = 284

Age, mean ± SDa

47.8 ± 11.8

Sex (%)

 Women

193 (68)

 Men

91 (32)

Household income (%)

 High (>60,000 CAD)

178 (62.7)

 Low

96 (33.8)

 Missing

10 (3.5)

Educational level (%)

 High

229 (80.6)

 Low

55 (19.4)

Place of birth (%)

 Canada

207 (72.9)

 Outside Canada

77 (27.1)

Ethnicity (%)

 Caucasian

231 (81.3)

 Asian

18 (6.3)

 Other

35 (12.4)

Residence type (%)

 Urban

260 (91.5)

 Rural

24 (8.5)

Asthma medication adherence (%)

 PDCb < 50 %

171 (60.2)

 50 % ≤ PDC < 80 %

31 (11)

 PDC ≥ 80 %

81 (28.5)

 Missing

1 (0.3)

Asthma control level (%)

 Controlled

55 (19.4)

 Partially Controlled

113 (39.8)

 Uncontrolled

115 (40.5)

 Missing

1 (0.3)

Productivity Loss (%)

136 (48)

Absenteeism (%)

49 (17)

Presenteeism (%)

127 (45)

Hours of overall productivity loss, mean ± SD

16 ± 17.6

Costsc of overall productivity loss, mean ± SD

317.49$ ± 858.83$

Overall SCQd comorbidities score, mean ± SD

2.47 ± 2.97

Heart disease (%)

15 (5.3)

Hypertension (%)

35 (12.3)

Diabetes (%)

9 (3.2)

Ulcer or Stomach Disease (%)

37 (13)

Kidney disease (%)

3 (1.1)

Liver disease (%)

2 (0.7)

Anemia or other blood disease (%)

21 (7.4)

Cancer (%)

6 (2.1)

Depression (%)

40 (14.1)

Osteoarthritis, degenerative arthritis (%)

62 (21.8)

Back pain (%)

99 (34.9)

Rheumatoid arthritis (%)

2 (0.7)

  1. aStandard deviation
  2. bproportions of days covered
  3. c2010 Canadian dollars
  4. dself-administered comorbidity questionnaire